0001237899-13-000022.txt : 20130416 0001237899-13-000022.hdr.sgml : 20130416 20130416123929 ACCESSION NUMBER: 0001237899-13-000022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130411 FILED AS OF DATE: 20130416 DATE AS OF CHANGE: 20130416 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McCorkle Douglas S CENTRAL INDEX KEY: 0001403178 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 13763227 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-04-11 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001403178 McCorkle Douglas S 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 VP Controller and Asst Treasur Common Stock 2013-04-11 4 M 0 5875.0 30.63 A 9875 D Common Stock 2013-04-11 4 F 0 879.0 204.57 D 8996 D Common Stock 2013-04-11 4 F 0 1867.0 204.57 D 7129 D Common Stock 2013-04-12 4 S 0 100.0 205.82 D 7029 D Common Stock 2013-04-12 4 S 0 100.0 207.32 D 6929 D Common Stock 2013-04-12 4 S 0 200.0 208.25 D 6729 D Common Stock 2013-04-12 4 S 0 482.0 209.48 D 6247 D Common Stock 2013-04-12 4 S 0 600.0 210.65 D 5647 D Common Stock 2013-04-12 4 S 0 731.0 211.47 D 4916 D Common Stock 2013-04-12 4 S 0 318.0 212.54 D 4598 D Common Stock 2013-04-12 4 S 0 298.0 213.12 D 4300 D Common Stock 2013-04-12 4 S 0 300.0 214.1 D 4000 D Common Stock 4066 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 30.63 2013-04-11 4 M 0 5875.0 D 2020-12-14 Common Stock 5875 8430 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 200 shares of Company stock on April 12, 2013 at prices ranging from $208.10 to $208.39. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 12, 2013 at each separate price. Represents volume-weighted average price of sales of 482 shares of Company stock on April 12, 2013 at prices ranging from $209.12 to $209.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 12, 2013 at each separate price. Represents volume-weighted average price of sales of 600 shares of Company stock on April 12, 2013 at prices ranging from $210.13 to $210.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 12, 2013 at each separate price. Represents volume-weighted average price of sales of 731 shares of Company stock on April 12, 2013 at prices ranging from $211.00 to $211.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 12, 2013 at each separate price. Represents volume-weighted average price of sales of 318 shares of Company stock on April 12, 2013 at prices ranging from $212.30 to $212.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 12, 2013 at each separate price. Represents volume-weighted average price of sales of 298 shares of Company stock on April 12, 2013 at prices ranging from $213.00 to $213.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 12, 2013 at each separate price. Represents volume-weighted average price of sales of 300 shares of Company stock on April 12, 2013 at prices ranging from $214.00 to $214.25. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 12, 2013 at each separate price. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. /s/**Douglas M. McCorkle 2013-04-16